A trial looking at improving chemoradiotherapy for people with cancer of the food pipe (SCOPE 2) | Cancer Research UK
More progress in detecting oesophageal cancer early - Cancer Research UK - Cancer news
Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends | Nature Reviews Gastroenterology & Hepatology
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Oesophageal cancer risk | Cancer Research UK
New option to treat advanced oesophageal cancer approved for NHS in Scotland - Cancer Research UK - Cancer news
See @TCCInsightTeam's Tweet on May 13, 2022 on Twitter / Twitter
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 -
Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients | PLOS ONE
Frontiers | VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2 ...
About Us — Department of Oncology
Oesophageal cancer risk | Cancer Research UK
Cell-free DNA analysis in current cancer clinical trials: a review | British Journal of Cancer
A trial of additional treatment for oesophageal cancer and stomach cancer (PLATFORM) | Cancer Research UK
Stage 0 (high grade dysplasia) | Oesophageal cancer | Cancer Research UK
Oesophageal cancer incidence statistics | Cancer Research UK
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial - The Lancet Oncology
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial - The Lancet Gastroenterology & Hepatology
Advances in targeted therapy for esophageal cancer | Signal Transduction and Targeted Therapy
Advances in the curative management of oesophageal cancer | British Journal of Cancer
Oesophageal cancer: risks, prevention, and diagnosis | The BMJ
Barrett's oesophagus | Signs and symptoms - Macmillan Cancer Support
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma | NEJM
.jpg?csf=1&web=1&e=dTEB7V "Immune boosting antibody trialled in patients with oesophageal cancer | Southampton Clinical Trials Unit | University of Southampton")
Immune boosting antibody trialled in patients with oesophageal cancer | Southampton Clinical Trials Unit | University of Southampton
Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study) - eClinicalMedicine
